CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 917 of 1
Non-Antibody Products
Page 917 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| PAMAM Dendrimer G1.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; inhibits MERS-CoV-induced plaque… | 1 g | 39106-1 | More Info |
| PAMAM Dendrimer G1.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; inhibits MERS-CoV-induced plaque… | 500 mg | 39106-500 | More Info |
| PAMAM Dendrimer G2.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; ~48.3 A in diameter in water and… | 1 g | 39107-1 | More Info |
| PAMAM Dendrimer G2.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; ~48.3 A in diameter in water and… | 500 mg | 39107-500 | More Info |
| PAMAM Dendrimer G3.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; has been used as a drug delivery… | 1 g | 39108-1 | More Info |
| PAMAM Dendrimer G3.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; has been used as a drug delivery… | 500 mg | 39108-500 | More Info |
| PAMAM Dendrimer G4.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; has been used in a drug delivery… | 1 g | 39109-1 | More Info |
| PAMAM Dendrimer G4.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; has been used in a drug delivery… | 500 mg | 39109-500 | More Info |
| PAMAM Dendrimer G5.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; has been used as a drug delivery… | 100 mg | 39110-100 | More Info |
| PAMAM Dendrimer G5.5 Carboxylate (sodium salt) (water solution) | A carboxylate-terminated PAMAM dendrimer; has been used as a drug delivery… | 50 mg | 39110-50 | More Info |
| PAMAM Dendrimer G2.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; has 16 surface groups; an an… | 1 g | 39119-1 | More Info |
| PAMAM Dendrimer G2.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; has 16 surface groups; an an… | 500 mg | 39119-500 | More Info |
| PAMAM Dendrimer G3.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; has been used as a drug deli… | 1 g | 39120-1 | More Info |
| PAMAM Dendrimer G3.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; has been used as a drug deli… | 500 µg | 39120-500 | More Info |
| PAMAM Dendrimer G4.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; has been used as a drug deli… | 1 g | 39121-1 | More Info |
| PAMAM Dendrimer G4.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; has been used as a drug deli… | 500 mg | 39121-500 | More Info |
| PAMAM Dendrimer G5.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; ~59 A in diameter; has 128 s… | 500 mg | 39122-500 | More Info |
| PAMAM Dendrimer G6.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; ~76 A in diameter in PBS and… | 100 mg | 39123-100 | More Info |
| PAMAM Dendrimer G6.0 Succinamic Acid (water solution) | A succinamic acid-terminated PAMAM dendrimer; ~76 A in diameter in PBS and… | 50 mg | 39123-50 | More Info |
| Pamapimod | A potent, selective inhibitor of p38α MAPK (IC50 = 14 nM); blocks in… | 1 mg | 20971-1 | More Info |
| Pamapimod | A potent, selective inhibitor of p38α MAPK (IC50 = 14 nM); blocks in… | 5 mg | 20971-5 | More Info |
| Pamapimod | A potent, selective inhibitor of p38α MAPK (IC50 = 14 nM); blocks in… | 500 µg | 20971-500 | More Info |
| Pam2CSK4 (trifluoroacetate salt) | A bacterial lipopeptide and TLR2 agonist; selective for TLR2 / TLR6 over T… | 1 mg | 33338-1 | More Info |
| Pam2CSK4 (trifluoroacetate salt) | A bacterial lipopeptide and TLR2 agonist; selective for TLR2 / TLR6 over T… | 5 mg | 33338-5 | More Info |
| Pam2CSK4 (trifluoroacetate salt) | A bacterial lipopeptide and TLR2 agonist; selective for TLR2 / TLR6 over T… | 500 µg | 33338-500 | More Info |
| Pam3CSK4 (trifluoroacetate salt) | A bacterial lipopeptide agonist of TLR2; induces proliferation of isolated… | 1 mg | 24126-1 | More Info |
| Pamicogrel | A COX inhibitor and an antiplatelet agent; inhibits arachidonic acid- or c… | 100 mg | 33514-100 | More Info |
| Pamicogrel | A COX inhibitor and an antiplatelet agent; inhibits arachidonic acid- or c… | 25 mg | 33514-25 | More Info |
| Pamicogrel | A COX inhibitor and an antiplatelet agent; inhibits arachidonic acid- or c… | 250 mg | 33514-250 | More Info |
| Pamicogrel | A COX inhibitor and an antiplatelet agent; inhibits arachidonic acid- or c… | 5 mg | 33514-5 | More Info |
| Pamidronate (sodium salt) | An FPP synthase inhibitor (IC50s = 0.85 and 0.20 µM in J774 cells an… | 100 mg | 23699-100 | More Info |
| Pamidronate (sodium salt) | An FPP synthase inhibitor (IC50s = 0.85 and 0.20 µM in J774 cells an… | 25 mg | 23699-25 | More Info |
| Pamidronate (sodium salt) | An FPP synthase inhibitor (IC50s = 0.85 and 0.20 µM in J774 cells an… | 250 mg | 23699-250 | More Info |
| Pamidronate (sodium salt) | An FPP synthase inhibitor (IC50s = 0.85 and 0.20 µM in J774 cells an… | 50 mg | 23699-50 | More Info |
| Pamiparib | A PARP1 and PARP2 inhibitor (IC50s = 1.3 and 0.92 nM, respectively); selec… | 10 mg | 33182-10 | More Info |
| Pamiparib | A PARP1 and PARP2 inhibitor (IC50s = 1.3 and 0.92 nM, respectively); selec… | 25 mg | 33182-25 | More Info |
| Pamiparib | A PARP1 and PARP2 inhibitor (IC50s = 1.3 and 0.92 nM, respectively); selec… | 5 mg | 33182-5 | More Info |
| Pamiparib | A PARP1 and PARP2 inhibitor (IC50s = 1.3 and 0.92 nM, respectively); selec… | 50 mg | 33182-50 | More Info |
| Pamoic Acid | A potent agonist of GPR35 orphan receptors (EC50 = 79 nM in a β-arres… | 100 g | 13946-100 | More Info |
| Pamoic Acid | A potent agonist of GPR35 orphan receptors (EC50 = 79 nM in a β-arres… | 250 g | 13946-250 | More Info |
| Pamoic Acid | A potent agonist of GPR35 orphan receptors (EC50 = 79 nM in a β-arres… | 50 g | 13946-50 | More Info |
| PAMP-12 (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) | An endogenous fragment and MRGPRX2 agonist; inhibits forskolin-induced cAM… | 1 mg | 36910-1 | More Info |
| PAMP-12 (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) | An endogenous fragment and MRGPRX2 agonist; inhibits forskolin-induced cAM… | 10 mg | 36910-10 | More Info |
| PAMP-12 (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) | An endogenous fragment and MRGPRX2 agonist; inhibits forskolin-induced cAM… | 25 mg | 36910-25 | More Info |
| PAMP-12 (human, mouse, rat, porcine, bovine) (trifluoroacetate salt) | An endogenous fragment and MRGPRX2 agonist; inhibits forskolin-induced cAM… | 5 mg | 36910-5 | More Info |
| pan-Akt (Phospho-Ser473) TR-FRET Assay Kit | This pan-Akt (Phospho-Ser473) TR-FRET Assay Kit uses a homogeneous TR-FRET… | 2400 Well | 500212-2400WELLS | More Info |
| pan-Akt (Phospho-Ser473) TR-FRET Assay Kit | This pan-Akt (Phospho-Ser473) TR-FRET Assay Kit uses a homogeneous TR-FRET… | 480 Well | 500212-480WELLS | More Info |
| pan-Akt (Phospho-Ser473) TR-FRET Assay Kit | This pan-Akt (Phospho-Ser473) TR-FRET Assay Kit uses a homogeneous TR-FRET… | 4800 Well | 500212-4800WELLS | More Info |
| pan-Akt (Phospho-Ser473) TR-FRET Assay Kit | This pan-Akt (Phospho-Ser473) TR-FRET Assay Kit uses a homogeneous TR-FRET… | 96 Well | 500212-96WELLS | More Info |
| pan-Akt (Phospho-Ser473) TR-FRET Assay Kit | This pan-Akt (Phospho-Ser473) TR-FRET Assay Kit uses a homogeneous TR-FRET… | 9600 Well | 500212-9600WELLS | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile